The Eye Center and The Eye Foundation for Research in Ophthalmology Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2004
NCT02766855
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

tacrolimus (prograf) (2 trials)

Drugs in Other Trials (1)

cysteamine (cystagon) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Conjunctivitis, Allergic (Phase 4)

Keratoconjunctivitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 2